Conference Day Two: Wednesday 29th September 2010

08.25 Chairperson’s Opening Address

Seth Pinsky
Director Scientific Informatics and Automation
Abbott Laboratories

08.30 CASE STUDY: Genentech A Year On: Executing A Successful User Adoption Strategy To Prevent Project Delays

• Understanding how users can be reticent in adopting a new technology into their working day as a fundamental key to gaining buy-in
• Designing a clear change management plan to help dilute push back
• Understanding the importance of incorporating end users into the project from the beginning
• Discussion of the roll-out at Genentech adding ~100 users/month

Martin Vanderlaan
Director, Analytical Operations
Genentech

09.15 Developing A Global Collaboration Platform To Drive Research Excellence

• Integrating analytical workflows from instruments to experiments
• Ensuring secure intellectual property
• How to effectively reduce the total cost of ownership

Debra Toburen
Senior Product Manager, Informatics
Agilent Technologies

10.30 The Lean Lab In Regulated Development & QC

• The role of ELNs in significantly improving laboratory efficiency while supporting GxP compliance efforts in regulated development and in QC
• How the integration of ELN with small devices, sophisticated instrumentation and LIMS reduces errors and waste and improves the laboratory workflow
• Electronic SOP documentation of the ELN removes major bottlenecks in the regulated laboratory

Dr. Thomas Schmidt
Senior Product Manager Informatics
Waters GmbH

11.00 CASE STUDY: Electronic Laboratory Notebooks: The Ideal Scientist’s Checklist

• Most experiments have become too complex for the scientist to remember all steps that must be performed for error free execution
• ELN’s can be programmed to be an ideal checklist for the scientist to follow for most procedures using templates
• Analyzing the protocol to capture the correct amount of detail for the checklist is an evolving art
• The checklist functions of the ELN are becoming more important as workflows expand across and include the contributions of multiple laboratories

11.45 CASE STUDY: Implementation Of An ELN In Biological And Bio-Technology Research Groups

• Requirements: how do they differentiate from chemistry environments?
• Workflow support: how to make life easier for the scientists
• Integration: what is needed inside the ELN, what is better kept outside
• Project management: agile versus waterfall approach – which to choose?

Dr Barbara Valastro
Director, in vitro Screening Drug Discovery & Development
Merz Pharmaceuticals GmbH

Dr Bernhard Schirm
Managing Director
quattro research GmbH

13.45 Panel Discussion: Research Virtualization: How To Use The Technologies Now Available Effectively

• How to successfully bring partners into the information flow
• Understanding the role of cloud computing in research data management and where are the gaps
• Microsoft SharePoint: a viable option for a pharmaceutical environment?

Michael Elliot
CEO
Atrium Research

Michael will be joined by other members of the speaker faculty

14.30 CASE STUDY: Enhancing Research Workflow Through GDC ELN Integrations At Novartis

• View on the status of the chemistry ELN at Novartis
• Integrating another vendor’s product: AWM;
• Understanding the benefits and challenges of going fully electronic: ERA
• What is the future of ELN at Novartis? Next versions? Other products?

Raquel Dias Miranda
Application Service Manager
Novartis Pharma AG

15.45 CASE STUDY: Ten Years Later: Basilea’s ELN In Chemistry

• Build vs. buy: what it takes to develop and evolve a proprietary ELN
• Structured vs. unstructured information in ELNs
• Chemistry awareness as the key to seamless integration
• Intellectual property protection: one step away from a paperless solution

Dr Adrian Brüngger-Brecht
Head of Discovery Informatics
Basilea Pharmaceutica

16.30 CASE STUDY: Implementing A Single ELN Across Biology In A Pharma Research Environment

• Understanding the challenges of an ELN implementation across a multi-site organization and a wide variety of activities (e.g. target research, protein production, HTS, in vivo pharmacology)
• Defining the rationale for one single ELN in Biology
• Defining and adopting a strong vendor selection strategy
• Understanding the importance of gaining user and management buy-in
• Planning for a smooth and multi-step deployment
• Establishing a clear change management strategy
• Importance of integration within a global Research Informatics landscape and strategy

Daniel Domine
Associate Director, Research Informatics
Merck-Serono

17.15 Chairperson’s Closing Remarks And Close Of Conference